Current position:Home >Product >
(E)-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]-4-(4-phenyl-2H-chromen-3-yl)but-3-enamide
(E)-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]-4-(4-phenyl-2H-chromen-3-yl)but-3-enamide
|
|
Canonical SMILES:
CC1=NC(=C(C(=C1)SC)NC(=O)CC=CC2=C(C3=CC=CC=C3OC2)C4=CC=CC=C4)SC
Isomeric SMILES
CC1=NC(=C(C(=C1)SC)NC(=O)C/C=C/C2=C(C3=CC=CC=C3OC2)C4=CC=CC=C4)SC
InChI
InChI=1S/C27H26N2O2S2/c1-18-16-23(32-2)26(27(28-18)33-3)29-24(30)15-9-12-20-17-31-22-14-8-7-13-21(22)25(20)19-10-5-4-6-11-19/h4-14,16H,15,17H2,1-3H3,(H,29,30)/b12-9+
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- (1S,3R,17S)-10,13-dimethyl-1,3-bis(oxan-2-yloxy)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol
- N'-(cyclopropylmethyl)-N-(2-methoxyethyl)-N'-[2-methyl-9-(2,4,6-trimethylphenyl)-5,6,7,8-tetrahydropyrido[2,3-b]indol-4-yl]ethane-1,2-diamine
- 1-(3-chlorophenyl)-4-[[3-[[4-(4-fluorophenyl)phenyl]methyl]imidazol-4-yl]methyl]piperazin-2-one
- 3-(4-hydroxyphenyl)-N-[(2S)-1-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-piperidin-1-yl]-3-methyl-butan-2-yl]propanamide hydrochloride
- N,N'-bis(2-azanylethyl)-2-[(3-bromophenyl)methyl]propane-1,3-diamine tetrahydrochloride
- N,N'-bis(2-azanylethyl)-2-[(3-bromophenyl)methyl]propane-1,3-diamine
- 1-[(3,4-dichlorophenyl)methyl]-4-[2-(2-oxidanylideneimidazolidin-1-yl)ethylcarbamoyl]indole-2-carboxylic acid
- 4-[[4-[[2,6-bis(chloranyl)pyridin-4-yl]oxymethyl]phenyl]sulfonylmethyl]-N-oxidanyl-oxane-4-carboxamide
- 1-[(3,4-dichlorophenyl)methyl]-4-[2-(4-methylpiperazin-1-yl)ethanoylamino]indole-2-carboxylic acid
- 4-[5,6-bis(chloranyl)-1,3-dihydrobenzimidazol-2-ylidene]-3-oxidanylidene-N-(1,2,2,6,6-pentamethylpiperidin-4-yl)cyclohexa-1,5-diene-1-carboxamide

